Gene · 22806
Papers2,106
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,106
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PBK/TOPK mediates Ikaros, Aiolos and CTCF displacement from mitotic chromosomes and alters chromatin accessibility at selected C2H2-zinc finger protein binding sites. | Nat Commun | 2025 | 40987773 | PubTator, text mining | PubMed |
| IBI-DT: a novel approach combining individualized Bayesian inference and decision tree for identifying cancer drivers and their interactions. | Brief Bioinform | 2025 | 40975833 | PubTator, text mining | PubMed |
| Dual functionality of MDM2 in PROTACs expands the horizons of targeted protein degradation. | Biomark Res | 2025 | 40866949 | PubTator, text mining | PubMed |
| Systemic Sclerosis with Interstitial Lung Disease: Identification of Novel Immunogenetic Markers and Ethnic Specificity in Kazakh Patients. | Epidemiologia (Basel) | 2025 | 40843700 | PubTator, text mining | PubMed |
| Adipocyte-derived factors induce adherent to suspension transition in breast and pancreatic cancer cells through lipid metabolic alteration. | Sci Rep | 2025 | 40836054 | PubTator, text mining | PubMed |
| Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics. | Nat Commun | 2025 | 40835825 | PubTator, text mining | PubMed |
| Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myeloma. | Biomark Res | 2025 | 40817326 | PubTator, text mining | PubMed |
| Initiation of meiosis from human iPSCs under defined conditions through identification of regulatory factors. | Sci Adv | 2025 | 40815662 | PubTator, text mining | PubMed |
| Regulatory role of E3 ubiquitin ligases in multiple myeloma: from molecular mechanisms to therapeutic strategies. | Front Cell Dev Biol | 2025 | 40809696 | PubTator, text mining | PubMed |
| IKZF3 promotes gastric cancer progression via Hedgehog signaling activation and is targetable by SANT-1. | Acta Biochim Biophys Sin (Shanghai) | 2025 | 40761106 | PubTator, text mining | PubMed |
| TLR4+group 2 innate lymphoid cells contribute to persistent type 2 immunity in airway diseases. | Nat Commun | 2025 | 40753172 | PubTator, text mining | PubMed |
| Exploring the zinc-binding proteins in the mutational hotspots of human cancer. | J Trace Elem Med Biol | 2025 | 40752378 | PubTator, text mining | PubMed |
| A rare case of pure non-gestational ovarian choriocarcinoma: Diagnostic mimicry and management strategies. | Oncoscience | 2025 | 40735309 | PubTator, text mining | PubMed |
| Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs. | Commun Chem | 2025 | 40730655 | PubTator, text mining | PubMed |
| [Multi-omics Mendelian randomization study on the causality between non-ionizing radiation and facial aging]. | Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi | 2025 | 40588408 | PubTator, text mining | PubMed |
| The Forgotten Innate Immune Cells: Unraveling Their Prospective Interactions with Nanomaterials. | Int J Nanomedicine | 2025 | 40584780 | PubTator, text mining | PubMed |
| Transcriptional regulatory logic orchestrating lymphoid and myeloid cell fate decisions. | Front Immunol | 2025 | 40510370 | PubTator, text mining | PubMed |
| Accommodating Statistical and Physics-Based Computational Protocols for Molecular Glue Model and Evaluation. | J Chem Inf Model | 2025 | 40492588 | PubTator, text mining | PubMed |
| CAR-T cell therapy clinical trials: global progress, challenges, and future directions from ClinicalTrials.gov insights. | Front Immunol | 2025 | 40463393 | PubTator, text mining | PubMed |
| Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function. | Acta Pharm Sin B | 2025 | 40370550 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/22806/papers?page=4